Gastroenterology News

In this Healio video, Aline Charabaty, MD clinical director of the Inflammatory Bowel Disease Center at Johns Hopkins, Sibley Memorial Hospital, discusses the underlying causes of ulcerative colitis.

In this Healio video, Aline Charabaty, MD clinical director of the Inflammatory Bowel Disease Center at Johns Hopkins, Sibley Memorial Hospital, discusses the underlying causes of ulcerative colitis.

In this Healio video, Aline Charabaty, MD clinical director of the Inflammatory Bowel Disease Center at Johns Hopkins, Sibley Memorial Hospital, discusses the underlying causes of ulcerative colitis.

Fruquintinib plus paclitaxel significantly improved PFS in patients with advanced gastric or gastroesophageal junction adenocarcinoma, according to results from a phase 3 trial presented during an ASCO Plenary Series session.

In this Healio video exclusive, Walker D. Redd, MD, discusses a study of patients with chronic diarrhea who underwent colonoscopy, which revealed 10% who had microscopic colitis “remained unaware” of their diagnosis 1 year after evaluation.

The FDA granted 510(k) clearance to Cyted’s EndoSign, a non-endoscopic capsule sponge device intended to gather pan-esophageal samples for early detection of esophageal cancer as well as other conditions, according to a company release.

Treatment with once-daily linaclotide was well-tolerated and resulted in significant improvement in spontaneous bowel movements and stool consistency vs. placebo among children with functional constipation, researchers reported.

Researchers estimated the global lifetime risk for developing gastrointestinal cancer in 2020 was one in 12 people, while one in 16 people will die, with colorectal cancer presenting the highest risk compared with other GI cancers.

Infliximab concentrations above 6.9 mg/L at 14 weeks after initiation of treatment predicted sustained remission between 26 and 52 weeks in children with inflammatory bowel disease, according to researchers in the Netherlands.

Incidence of new portal vein thrombosis was higher after transarterial chemoembolization for hepatocellular carcinoma compared with microwave or radiofrequency ablation, although researchers reported no clinically significant sequalae.